Pump controlled retrograde trial off using the Cardiohelp console: safety considerations

Mattke, Adrian; Haisz, Emma; Black, Anthony; Venugopal, Prem

doi:10.1177/0267659119865827

Cited by 3 publications

(3 citation statements)

References 6 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, concerns regarding flushing back potentially accumulated circuit clots or embolic load remain unresolved. [29][30][31][32]…”

Section: Controlled Automated Reperfusion Of the Whole Bodymentioning

confidence: 99%

Year in review: Highlights in ECLS Innovation and Technology, Anno 2022-2023

Vercaemst

2023

Perfusion

View full text Add to dashboard Cite

Background In the field of extracorporeal life support (ECLS), the rapid influx of novel technologies and innovative techniques presents an ongoing challenge for professionals to stay informed about these advancements. To address this issue and ensure the ECLS community remains up-to-date, we have compiled a concise overview of recent technological innovations in ECLS. Purpose This overview focuses primarily on academically investigated and reported advancements in the ECLS domain. It underscores the importance of transparent communication regarding technological limitations in healthcare and advocates for collaboration between medical professionals and engineers to elevate patient care. Research Design This manuscript presents a compilation of recent technological advancements in ECLS, with an emphasis on innovations that have been academically explored and documented. The research approach involves gathering information from scholarly sources, reports, and studies to provide a comprehensive overview. Study Sample The study sample comprises a diverse range of recent technological innovations in the field of extracorporeal life support (ECLS). These innovations span various aspects of ECLS technology and have been investigated and reported on within the academic literature. Analysis Data collection involved systematically reviewing academic literature, reports, and studies related to recent technological advancements in ECLS. The collected information was then analyzed to identify common trends, notable developments, and the impact of these innovations on patient care. Results The compilation highlights several significant technological innovations within the ECLS domain. Notable advancements include the development of new dual lumen cannulae, innovative devices for left ventricular (LV) unloading, lightweight ECMO transport systems, streamlined driving consoles to facilitate patient mobility, intricate systems for extracorporeal cardiopulmonary resuscitation (ECPR), standardized driving consoles for networking, and non-invasive circuit pressure monitoring. Some of these innovations have obtained regulatory approvals for distribution in the United States and/or authorization for the European market. Conclusions The manuscript underscores the critical role of collaboration between clinicians, researchers, and industry in driving recent technological innovations within the ECLS field. It emphasizes the necessity of open communication about technological limitations and the potential for repurposing established technologies in novel ways. However, the resourcefulness of physicians in repurposing devices requires validation through comprehensive scientific and technical investigation. Thus, fostering broader collaboration among stakeholders is recommended to ensure the rigorous evaluation and validation of new applications for established ECLS devices.

show abstract

“…However, concerns regarding flushing back potentially accumulated circuit clots or embolic load remain unresolved. [29][30][31][32]…”

Section: Controlled Automated Reperfusion Of the Whole Bodymentioning

confidence: 99%

Year in review: Highlights in ECLS Innovation and Technology, Anno 2022-2023

Vercaemst

2023

Perfusion

View full text Add to dashboard Cite

show abstract

“…Several studies have suggested that PCRTO is a safe and reproducible approach. 1,3,5 We read with interest the letter by Mattke et al 6 raising issues about safety considerations during PCRTO. The authors rightfully point out the risk of blood stagnation because of an unintended PCRTO cessation due to "back flow prevention. "…”

mentioning

confidence: 99%

“…We read with interest the letter by Mattke et al 6 raising issues about safety considerations during PCRTO. The authors rightfully point out the risk of blood stagnation because of an unintended PCRTO cessation due to “back flow prevention.” This strategy is commonly used at our centers with the Cardiohelp™ system (Maquet, Rastatt, Germany) and technical aspects of this procedure, which are not detailed in most studies, should be highlighted.…”

mentioning

confidence: 99%